Holen Sie sich die Stockscreener-App
21.70
2.12%
0.45
Handel nachbörslich:
21.77
0.07
+0.32%
Schlusskurs vom Vortag:
$21.25
Offen:
$21.04
24-Stunden-Volumen:
229.22K
Relative Volume:
3.14
Marktkapitalisierung:
$237.51M
Einnahmen:
$56.54M
Nettoeinkommen (Verlust:
$-30.70M
KGV:
-55.64
EPS:
-0.39
Netto-Cashflow:
$-31.05M
1W Leistung:
-9.58%
1M Leistung:
-4.87%
6M Leistung:
+66.79%
1J Leistung:
+52.39%
1-Tages-Spanne:
$20.76
$22.00
1-Wochen-Bereich:
$19.87
$24.39
52-Wochen-Spanne:
$10.00
$28.42
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Vergleichen Sie CDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
21.70 | 237.51M | 56.54M | -30.70M | -31.05M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - MSN
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Update - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
Geode Capital Management LLC Buys 9,771 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
(CDTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Shares Cross Above 50 Day Moving AverageTime to Sell? - MarketBeat
Cidara Therapeutics announces board changes, CMO separation - Investing.com
Cidara Therapeutics Announces Leadership Changes and Appointments - MSN
Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives $32.20 Average PT from Analysts - Defense World
Cidara Therapeutics stock soars to 52-week high of $24.99 By Investing.com - Investing.com Nigeria
Cidara Therapeutics stock soars to 52-week high of $24.99 - Investing.com
(CDTX) Proactive Strategies - Stock Traders Daily
Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $32.20 - MarketBeat
Influenza A Infections Market Overview: Size, Share, and Future - openPR
Cidara Therapeutics files to sell 7.04M shares of common stocks by selling shareholders - MSN
Long Term Trading Analysis for (CDTX) - Stock Traders Daily
Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Cidara Therapeutics stock soars to 52-week high of $24.4 - Investing.com
Cidara Therapeutics (NASDAQ:CDTX) versus Ginkgo Bioworks (NYSE:DNA) Financial Survey - Defense World
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Increase in Short Interest - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Coverage Initiated at Royal Bank of Canada - Defense World
RBC Capital Initiates Coverage of Cidara Therapeutics (CDTX) with Outperform Recommendation - MSN
Cidara Therapeutics (NASDAQ:CDTX) Now Covered by Analysts at Royal Bank of Canada - MarketBeat
Cidara achieves full enrolment in influenza prevention trial - Yahoo Finance
RA Capital Management L.P. Takes $7.56 Million Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - MarketBeat
Cidara Therapeutics Completes Enrollment of Phase 2b - GlobeNewswire
Cidara Achieves Major Milestone: 5,000 Patients Enrolled in Game-Changing Universal Flu Prevention Trial - StockTitan
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Finance Watch: PIPEs Still Key Even As FOPO Fundraising Climbs - Citeline News & Insights
(CDTX) Trading Report - Stock Traders Daily
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Cidara Therapeuti - GuruFocus.com
ATB’s €54M series A among largest ever in Belgium - BioCentury
Cidara Therapeutics announces $105 million private placement By Investing.com - Investing.com South Africa
Cidara Therapeutics announces $105 million private placement - Investing.com India
Cidara: Potential To Change Flu Prophylaxis Landscape With CD388 - Seeking Alpha
Cidara to raise up to $105 million in private placement - The Pharma Letter
Cidara Therapeutics shares surge on $105M equity private placement - MSN
Cidara Therapeutics Shares Surge 26% on $105 Mln Private Placement - MarketWatch
Cidara Therapeutics Announces $105 Million Private Placement - GlobeNewswire
Cidara Therapeutics Secures $105M Private Placement Led by Venrock Healthcare | CDTX Stock News - StockTitan
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference - GlobeNewswire
Cidara Therapeutics CEO to Present at Evercore HealthCONx Conference | CDTX Stock News - StockTitan
(CDTX) Technical Data - Stock Traders Daily
HC Wainwright Has Positive Outlook of CDTX FY2024 Earnings - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Given Buy Rating at HC Wainwright - MarketBeat
Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $29.67 - MarketBeat
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):